At a glance
Selected studies address an intratesticular hormone response, a two-preparation pharmacokinetic comparison, and sperm outcomes during hCG plus FSH treatment in a specific diagnosis.
Identity & scope
hCG is a reproductive hormone. Source, molecular preparation, activity units and formulation matter; a catalogue label alone is insufficient to establish equivalence to a studied medicine.
What the research shows
- Intratesticular testosterone is a physiological measurement, distinct from sperm outcomes, conception or sexual performance.
- The comparison of specified medicines demonstrates the importance of formulation-specific exposure data.
Critical interpretation
The hormone marker is not the fertility outcome
The testosterone-suppression experiment directly sampled intratesticular testosterone, an informative local endocrine measurement. It was not designed to establish conception or a sexual-function benefit. The longer study reaches sperm and pregnancy outcomes, but adds follitropin alfa after an hCG phase in men with severe hypogonadotropic hypogonadism. Its results belong to that combined regimen and diagnosis. They cannot isolate what hCG alone contributed or predict a similar outcome in a different population. [1] [3]
Preparation-specific exposure is an evidence question
The crossover comparison of highly purified and recombinant hCG provides a practical reason to retain the preparation details in a citation. Exposure differed between the two specified medicines, even though both were described as hCG. A biological name therefore does not settle formulation equivalence. It is particularly important not to transfer an injected-medicine result to a catalogue nasal label without a direct pharmacokinetic bridge. That gap concerns measured delivery, not merely the wording of the product name. [2]
Limitations & uncertainties
- The endocrine experiment used induced gonadotropin suppression and short follow-up.
- These sources do not establish effects of catalogue nasal hCG or interchangeability between preparations.
Open research questions
- Does the material documentation specify source, biological activity and complete formulation?
- Is the outcome being discussed hormonal, reproductive or sexual, and was it directly measured?
Selected papers & source records
Download bibliography1. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression (opens in a new tab)
Coviello AD, Matsumoto AM, Bremner WJ, et al. (2005). Journal of Clinical Endocrinology & Metabolism. DOI: 10.1210/jc.2004-0802 (opens in a new tab) · PMID 15713727
- Design & population
- Twenty-nine men were randomized to testosterone-induced gonadotropin suppression plus placebo or graded hCG exposure for three weeks; testicular-fluid testosterone was measured.
- What the study found
- hCG exposure was associated with dose-related maintenance of intratesticular testosterone despite gonadotropin suppression.
- Limits on interpretation
- An experimentally altered endocrine setting with a hormone endpoint. The study did not establish improved fertility, sexual performance or the effects of nasal hCG.
2. Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy Women (opens in a new tab)
Radicioni M, Leuratti C, Cometti B. (2022). Clinical Drug Investigation. DOI: 10.1007/s40261-022-01118-w (opens in a new tab)
- Design & population
- Randomized two-way crossover comparison of two specified hCG medicines in 26 healthy women;24 were included in the pharmacokinetic analysis.
- What the study found
- The preparations produced differing exposure and peak-concentration results, illustrating why formulations and sources cannot be treated as automatically interchangeable.
- Limits on interpretation
- A formulation-specific pharmacokinetic comparison. It was not a comparison with catalogue hCG or a study of sexual-function outcomes.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
3. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism (opens in a new tab)
Matsumoto AM, Snyder PJ, Bhasin S, et al. (2009). Fertility and Sterility. DOI: 10.1016/j.fertnstert.2008.07.1742 (opens in a new tab) · PMID 18930190
- Design & population
- Open-label noncomparative multicentre study in 36 men with severe hypogonadotropic hypogonadism. hCG treatment was followed by combined hCG and follitropin alfa.
- What the study found
- Sperm production developed in many participants during combination treatment, and five clinical pregnancies were reported.
- Limits on interpretation
- No comparator and a combination intervention: the study cannot isolate an hCG-alone effect or predict results in men without this diagnosis.
Search & review scope
Targeted web searches of PubMed-indexed primary research and original journal records. Selected abstracts and citation metadata were checked; full-text sections were consulted for the records explicitly labelled full-text. Retrieved records and targeted notice searches were also checked for visible corrections or retractions.. Checked 9 November 2026.
Selected primary research relevant to the named compound, its molecular specification and the endpoints described below.
Narrative selection, not a systematic review, comprehensive safety assessment or complete retraction audit. PubMed/PMC full-text access was intermittent. An abstract or selected-section review cannot replace appraisal of the complete methods, supplements and underlying data. Absence from this selection does not establish absence of research.
Recorded search terms
- 15713727 human chorionic gonadotropin
- "Low-dose human chorionic gonadotropin maintains intratesticular testosterone"
- "Randomized Pharmacokinetic Study" "Choriomon" authors
- site.pubmed.ncbi.nlm.nih.gov hCG recombinant FSH hypogonadotropic men spermatogenesis multicenter prospective
- "18930190" authors DOI
Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.
Cite this review
HeartPep. Human chorionic gonadotropin (hCG): literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/hcg.
HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.
Buy from HeartPep.com
Laboratory research only. Not for human or veterinary use.